Johnson & Johnson is working on a bid for $10bn neuroscience drugmaker Intra-Cellular Therapies, in what would be the biggest biotech deal in more than a year, according to people familiar with the ...

JOHNSON & Johnson (J&J) is in talks to acquire Intra-Cellular Therapies, a biopharmaceutical company focused on treatments ...

Johnson & Johnson is in talks to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter said.

Saks Fifth Avenue is known for selling luxe, chic clothing and accessories — we rounded up 12 deals to shop during its ...